Exchange Bulletin

Willow Biosciences Inc. (WLLW) To Trade On Toronto Stock Exchange

December 3, 2019
Issuer: Willow Biosciences Inc. (the "Company")
Security: Common shares
Symbol(s): WLLW
Number of securities issued and outstanding: 78,891,879
Number of securities reserved for issuance: 33,069,223
Listing category: Industrial, Non-Exempt Issuer
Trading currency: CDN$
Listing date: December 4, 2019 (as at 5:01 pm)
Posted for trading date: December 5, 2019 (at the opening)
Other market(s): The common shares have been listed on the Canadian Securities Exchange ("CSE") since April 15, 2019 under the symbol "WLLW". TSX is advised that the common shares will be delisted from the CSE on December 4, 2019 (at the close).
Temporary market maker: W.D. Latimer Co. Ltd.
Security ownership registration: Non-certificated inventory
Investor relations: Troy Talkkari
Vice President, Corporate Development
Incorporation: Business Corporations Act (Alberta)
Fiscal year end: December 31
Nature of business: The Company is a biotechnology company focusing on developing yeast as a production platform for high-grade pharmaceutical ingredients typically sourced from plants. Currently, the Company is focused on genetically engineering yeast strains to produce economically viable titers of cannabinoids.
Transfer agent and registrar: Alliance Trust Company at its principal office in Calgary.
Dividends: None anticipated in the foreseeable future.
Sponsorship: Eight Capital
TSX contact: Chris Birkett,
Toronto Stock Exchange.